Concepedia

Xiao Wu

XW

Statistics

Publications

15

Citations

1.1K

H-Index

11

Active since

2004

Affiliations

Moffitt Cancer Center(Current)

Theravance Biopharma (United States)

Orlando Health

University of Louisville

University of Colorado Denver

Xiao Wu is an author at Moffitt Cancer Center specializing in cellular therapies, tumor immunology, and immune cell therapy.

ORCID

Top concepts

Publications per year

2004–2023

15

Publications

15

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani et al. · Journal of Clinical Oncology · 2021 · 373 citations · Full text

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study

Jason Chesney, Karl D. Lewis, Harriet M. Kluger et al. · Journal for ImmunoTherapy of Cancer · 2022 · 268 citations · Full text

The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer

Qiang Zhou, Rui Peng, Xiao Wu et al. · Journal of Translational Medicine · 2010 · 215 citations · Full text

Speeding up in Vitro Discovery of Structure-Switching Aptamers via Magnetic Cross-Linking Precipitation

Na Qiao, Jing Li, Xiao Wu et al. · Analytical Chemistry · 2019 · 34 citations

492 Phase 2 efficacy and safety of autologous tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab in immune checkpoint inhibitor-naïve patients with advanced cancers

David M. O’Malley, Sylvia Lee, Amanda Psyrri et al. · Regular and Young Investigator Award Abstracts · 2021 · 34 citations · Full text

, , +24

1–5 of 15